Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | DVA | GILD |
|---|
| Close | 187.50 | 170.68 |
| Market Cap | $11.6B | $213B |
| 1M | +7.19% | +14.51% |
| P/E (TTM) | 13.5 | — |
| Forward P/E | 12.4 | 22.0 |
| P/E 5-Yr Percentile | 19 | — |
| P/S | 0.8 | 7.0 |
| P/B | 94.5 | 17.9 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $3.6B | $8.3B |
| Revenue YoY | +4.6% | +6.8% |
| Gross Margin | — | 81.1% |
| Latest Quarter EPS | 3.40 | 1.94 |
| Avg Post-Earnings Move | ±12.9% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 6.26% | 2.57% |
| 90-Day Net Insider Buying | — | −$15.9M |
DVA · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
